The global glucose monitoring devices market is expected to reach US$ 21.8 Bn in 2027 from US$ 12.6 Bn in 2018. The market is estimated to grow with a CAGR of 6.4% from 2019-2027.
The market is driven by the factors such as, rising incidence of diabetes, growing geriatric population, increasing prevalence of obesity across the globe, and rapid technological advancement in Glucose Monitoring devices. However, the factors restraining the market growth are high cost of glucose monitoring devices.
Obesity, sedentary lifestyle and improper diet play a major role in increasing diabetes among the population worldwide. Physical activity is important to maintain the blood glucose level. Lack of exercise and unhealthy diet such as diet high in fat and calories increase the risk for the development of obesity and diabetes. Obesity is one of the major problem and the biggest concern in all the communities across the globe. Currently, more than one in two adults and nearly one in six children are obese. Obesity is one of the major issue affect people of all ages and incomes globally. According to World Health Organization (WHO), in 2016, more than 1.9 billion adults aged 18 years and older were overweight. And out of these over 650 million adults were obese. Therefore, owing to these factors the market is likely to witness growth during the forecast period.
Global glucose monitoring devices market was segmented by product and end user. The product segment was further divided as Glucometers, Lancets, Testing Strips and Other Glucose. The test strips segment is expected to dominate the market owing to the rise in the prevalence of the diabetes and rise in number of blood glucose monitoring tests. Based on the end user the glucose monitoring device market is segmented into hospitals and clinics and home care. The homecare held the major market share among the end user segment owing to ease of use, availability, and accessibility of glucose monitoring devices.
Some of the major primary and secondary sources included in the report for the glucose monitoring devices market are World Health Organization, American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation and others.
The market is driven by the factors such as, rising incidence of diabetes, growing geriatric population, increasing prevalence of obesity across the globe, and rapid technological advancement in Glucose Monitoring devices. However, the factors restraining the market growth are high cost of glucose monitoring devices.
Obesity, sedentary lifestyle and improper diet play a major role in increasing diabetes among the population worldwide. Physical activity is important to maintain the blood glucose level. Lack of exercise and unhealthy diet such as diet high in fat and calories increase the risk for the development of obesity and diabetes. Obesity is one of the major problem and the biggest concern in all the communities across the globe. Currently, more than one in two adults and nearly one in six children are obese. Obesity is one of the major issue affect people of all ages and incomes globally. According to World Health Organization (WHO), in 2016, more than 1.9 billion adults aged 18 years and older were overweight. And out of these over 650 million adults were obese. Therefore, owing to these factors the market is likely to witness growth during the forecast period.
Global glucose monitoring devices market was segmented by product and end user. The product segment was further divided as Glucometers, Lancets, Testing Strips and Other Glucose. The test strips segment is expected to dominate the market owing to the rise in the prevalence of the diabetes and rise in number of blood glucose monitoring tests. Based on the end user the glucose monitoring device market is segmented into hospitals and clinics and home care. The homecare held the major market share among the end user segment owing to ease of use, availability, and accessibility of glucose monitoring devices.
Some of the major primary and secondary sources included in the report for the glucose monitoring devices market are World Health Organization, American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation and others.
Table of Contents
1. INTRODUCTION
4. GLUCOSE MONITORING DEVICES MARKET LANDSCAPE
5. GLUCOSE MONITORING DEVICES MARKET - KEY MARKET DYNAMICS
6. GLUCOSE MONITORING DEVICES MARKET - GLOBAL MARKET ANALYSIS
7. GLUCOSE MONITORING DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8. GLUCOSE MONITORING DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9. GLUCOSE MONITORING DEVICES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10. INDUSTRY LANDSCAPE
11. GLUCOSE MONITORING DEVICES MARKET, KEY COMPANY PROFILES
12. APPENDIX
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- F. Hoffmann-La Roche Ltd.
- B. Braun Melsungen AG
- Medtronic
- Abbott
- LifeScan, Inc.
- Ascensia Diabetes Care Holdings AG
- Ypsomed AG
- Omron Corporation
- GE Healthcare
- Nipro Corporation